Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think this is a valid concern. He hasn't accomplished anything in his earlier years when his mind was fresh and working for a lot of startups. Now he's almost at retirement age, who would invest in him now? Also, have you ever seen anyone come out with a breakthrough tech idea in their 50s?
Regarding Lebby's age, an interesting new topic, worth considering:
1/2 $LWLG More food for thought. The CEO Lebby is 59 years old. Has anyone ever seen someone come out with a breakthrough tech product at that age? Look at the disgraced CEO of $INTZ, Enron, Unilife, etc., all old guys at the helm of companies with "new" tech ideas.
— Adam Gefvert, CFA (@Shiningboy) September 20, 2021
A little LWLG humor
$LWLG 😂 pic.twitter.com/aLJLj5rUF1
— White Diamond (@WhiteResearch) September 14, 2021
Any hint on when commercialization is going to happen?
Interactive brokers and Schwab.
I am invested in LWLG. I'm short. That's as much of an investment as going long.
Pump is over, now time for the dump. $3.50 in one month. $1 in a year.
What do you mean? Did you read his post? This is what he said:
"his garbage SA hit piece not even getting an ounce of traction"
LWLG is down 10% today. Is that an ounce of traction?
Oops, this post didn't age well.
That's a very perceptive observation, Koog. Thanks.
Why A Cybersecurity Expert Who Calls Intrusion And Its New Shield Product “Garbage” - $4 Price Target (INTZ)
Here are the summary points:
Intrusion (INTZ) hired a promotional CEO last year, launched a new product called Shield, and its stock has risen 800%+.
Shield has no patents, certifications, or insurance, which are all essential for a new cybersecurity product.
Shield is based on open-source data already available to the public.
The datasheets and white papers on INTZ’s website don’t show details on what their products do, they just have empty buzzwords.
The companies that took part in Shield’s beta test case study are associated parties.
INTZ’s new chairman of the board, Tony LeVecchio, was also the chairman of the board for UniPixel (UNXLQ), which was a touch screen technology pump and dump scam that went bankrupt and faced SEC charges.
INTZ’s own investor relations rep said the former CFO, who was with the company for 34 years, resigned because he’s “scared to death”.
The Paxton family sold hundreds of thousands of INTZ at $8 apiece in October of last year, and are continually selling shares today, with millions more shares to go.
Read the full report here
https://whitediamondresearch.com/research/why-we-agree-with-a-cybersecurity-expert-who-calls-intrusion-and-its-new-shield-product-garbage-4-price-target/
Thanks for the info, Sam. You mentioned the Super-8k. What is it? Why is it called "Super"? And when do you expect it to come? Thanks.
I think something else just got filled...
You got merked. You lost 33% of your investment in about 15 minutes.
Activist letter to the FDA regarding UEEC!
https://whitediamondresearch.com/archive/activist-letter-to-the-fda-suggesting-united-health-products-ueec-has-the-wrong-regulatory-path/
Your equating a question of which hand he wipes his ass with, with whether or not he lied about going to Harvard? You deserve to lose all your money.
How about simply ask Justin - did you really graduate from Harvard?
Notes on Marin SOftware's undeserved 2 day rally:
http://whitediamondresearch.com/archive/notes-on-marin-softwares-mrin-undeserved-two-day-rally/
Hey, I'm looking to join the bagholders R Us message board. Is this one it?
Problem with that logic is your going to join the criers.
Cost of U.S. opioid epidemic tops $500B
Nov. 20, 2017 4:58 AM ET|By: Yoel Minkoff, SA News Editor
In an analysis to be released today, the White House will say the true cost of the opioid drug epidemic in 2015 was $504B, more than six times larger than the most recent estimate.
Most of that was attributed to healthcare and criminal justice spending, along with lost productivity.
President Trump last month declared opioid abuse a national public health emergency.
https://seekingalpha.com/news/3313390-cost-u-s-opioid-epidemic-tops-500b?ifp=0
GRST just announced it put down its first deposit for a 174 bed facility. That locks in the purchase of such a big new facility.
News here:
https://finance.yahoo.com/news/ethema-health-completes-first-deposits-130000589.html
This is an interesting, detailed article from yesterday about how the opioid epidemic has ravaged West Virginians, and how they are fighting back.
https://www.huffingtonpost.com/entry/west-virginia-opioid-addiction-podcast_us_59f89806e4b0aec1467b0026?utm_medium=email&utm_campaign=__TheMorningEmail__110117&utm_content=__TheMorningEmail__110117+CID_ac1e708e4295a1cd176f1f311bd94e15&utm_source=Email%20marketing%20software&utm_term=HuffPost&ncid=newsltushpmgnews__TheMorningEmail__110117
Interesting. The group most likely to get addicted to opioids are middle aged women. From this article: https://www.aol.com/article/lifestyle/2017/10/07/this-is-the-group-thats-more-likely-to-be-prescribed-opioids-and-get-addicted/23236001/
That is the group most likely to undergo surgeries, which is the gateway to opioid prescriptions.
Wow, Ethema got the big detox center! They just acquired a 174 bed addiction treatment center in West Palm Beach. This company is on its way to doing big things. Here's the 8-K:
https://www.sec.gov/Archives/edgar/data/792935/000072174817000686/grst8k100417.htm
Very sad the destruction of the opioid crisis in some areas in the US. An article today:
http://www.huffingtonpost.com/entry/opioid-overdoses-dead-bodies-west-virginia_us_59c92612e4b06ddf45f9f23a?utm_medium=email&utm_campaign=__TheMorningEmail__092717&utm_content=__TheMorningEmail__092717+CID_b2ad07af10f45aa718cee2f1c6652830&utm_source=Email%20marketing%20software&utm_term=HuffPost&ncid=newsltushpmgnews__TheMorningEmail__092717
By investing in GRST, you are getting involved in the fight against drug addiction. The following are actors who have died of a drug overdose:
https://www.cheatsheet.com/entertainment/actors-died-overdose.html/?utm_source=Sailthru&utm_medium=email&utm_campaign=Daily%20Cheat%20Sheet%202017-09-25&utm_term=Daily%20Cheatsheet
I exchanged emails with GRST's CEO, Shawn Leon, a couple days ago. He said there has been no damage to the facilities. And the patients were moved to backup facilities so there wasn't any interruption in treatment.
This filing: https://seekingalpha.com/filing/3694245
Is causing the collapse. Looks pretty horrible. The departing CFO is getting paid $2.5M. Company only has about $8M right now. And, he retains options for 948K shares of OPNT stock, exercisable ASAP! You can bet some of these shares sold today is him.
Ethema Health (GRST) is a ground floor opportunity in the hot substance abuse treatment industry. AAC and ACHC are the only two other publicly traded pure plays in the sector. They have been going nuts. GRST is just starting out and has potential 10x bagger potential.
See the report on whitediamondresearch.com. See tweets from White Diamond about $GRST on twitter @whiteresearch.
Questions For the Star Scientific Experts:
Hello,
I'm considering taking a position in STSI, and I have some questions that concern me. If you can answer any one of the following questions, or guide me to the answer, it would be helpful (you don't have to know the answers to them all).
They are:
1. Is there a lockup period for the recent warrant conversion? Do you know if these new holders plan to sell their shares anytime soon? They got to exercise their warrants for quite a bit less than the market price for the stock.
2. Why did quarter on quarter growth slow down so much from Q2 to Q3? It went from 36% growth in Q2 to only 10% growth in Q3. What is the expected growth in Q4 and 2013?
3. Why is the gross margin so different in each quarter? In Q1 it was 21%, Q2 33%, and Q3 10%. Has the ingredients to Anatabloc gotten more expensive?
4. Are there any catalysts for the company coming up in 2013?
5. Why did the company only get $5 million for the RJR verdict? Wasn't it supposed to be in the hundreds of millions?
6. The CEO is only taking $1 per month in compensation until the company becomes profitable. Does that mean he won't get any share based compensation either? How does he plan to make the company profitable? Will it be only if anatabloc gets approval as a prescription drug?
Thanks in advance.
Above, I see a conference in July, a 45 minute CC in July, and another conference in August. Those three events caused the stock to jump 5 fold?
This stock was trading for under 50 cents in June. What events and data has happened to cause it to jump 5x in value? Or has the rise been all hype and rumors?